3899 |
Optimal Antithrombotics for Complex Patients: Different Drugs, Dosing, or Duration? |
Davide Capodanno |
Apr. 27. 19 |
3898 |
Anticoagulation for TAVR: GALILEO, and Yet It Moves. |
Duk-Woo Park |
Apr. 27. 19 |
3897 |
Deep Dive into Mitraclip Trials for Functional MR |
Gregg W. Stone |
Apr. 27. 19 |
3896 |
Case 1: Unexpanded ISR - Challenging and Optimal Treatment |
Jung-Min Ahn |
Apr. 27. 19 |
3895 |
Mechanical Properties of the Magmaris Bioresorbable Scaffold |
John Ormiston |
Apr. 27. 19 |
3894 |
Practical Considerations for Long DAPT Based on Lesion and Patient Selections |
Tullio Palmerini |
Apr. 27. 19 |
3893 |
Ultra Low-profile, Everolimus Cr-Co Stent with Absorbable Polymer: Multicenter, OCT Study |
Upendra Kaul |
Apr. 27. 19 |
3892 |
Short DAPT Programs in HBP Patients: What Are Ongoing? |
Marie-Claude Morice |
Apr. 27. 19 |
3891 |
Insights from Pathology Studies: DCBs and DESs |
Aloke V. Finn |
Apr. 27. 19 |
3890 |
LM Bifurcation |
Duk-Woo Park |
Apr. 27. 19 |